A detailed history of Tranquility Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Tranquility Partners, LLC holds 5,292 shares of BSX stock, worth $447,438. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,292
Previous 5,292 -0.0%
Holding current value
$447,438
Previous $362,000 12.43%
% of portfolio
0.16%
Previous 0.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$57.6 - $68.62 $3,974 - $4,734
-69 Reduced 1.29%
5,292 $362,000
Q4 2023

Jan 31, 2024

BUY
$48.64 - $57.81 $5,836 - $6,937
120 Added 2.29%
5,361 $309,000
Q4 2022

Feb 02, 2023

SELL
$39.56 - $47.22 $242,067 - $288,939
-6,119 Reduced 53.86%
5,241 $242,000
Q3 2022

Oct 31, 2022

BUY
$36.71 - $109.66 $2,973 - $8,882
81 Added 0.72%
11,360 $440,000
Q2 2022

Aug 01, 2022

BUY
$35.24 - $47.1 $4,264 - $5,699
121 Added 1.08%
11,279 $420,000
Q1 2022

Apr 29, 2022

BUY
$40.9 - $45.1 $9,488 - $10,463
232 Added 2.12%
11,158 $494,000
Q4 2021

Jan 31, 2022

BUY
$38.07 - $44.87 $14,656 - $17,274
385 Added 3.65%
10,926 $464,000
Q3 2021

Oct 20, 2021

SELL
$41.23 - $45.88 $189,286 - $210,635
-4,591 Reduced 30.34%
10,541 $457,000
Q2 2021

Jul 23, 2021

BUY
$38.58 - $44.24 $9,259 - $10,617
240 Added 1.61%
15,132 $647,000
Q1 2021

Apr 30, 2021

BUY
$35.27 - $39.67 $326,600 - $367,344
9,260 Added 164.42%
14,892 $576,000
Q3 2020

Nov 10, 2020

SELL
$34.44 - $42.23 $5,613 - $6,883
-163 Reduced 2.81%
5,632 $215,000
Q2 2020

Jul 29, 2020

BUY
$30.19 - $39.11 $174,951 - $226,642
5,795 New
5,795 $203,000
Q1 2020

Apr 20, 2020

SELL
$25.83 - $45.71 $277,543 - $491,153
-10,745 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$37.87 - $45.37 $16,662 - $19,962
440 Added 4.27%
10,745 $486,000
Q2 2019

Aug 13, 2019

BUY
$34.91 - $42.98 $359,747 - $442,908
10,305 New
10,305 $443,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Tranquility Partners, LLC Portfolio

Follow Tranquility Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tranquility Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tranquility Partners, LLC with notifications on news.